Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

TOPIRAMATE

TOPIRAMATE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TOPIRAMATE is listed in Drugs@FDA under application 215414 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TOPIRAMATE Form and strength TABLET;ORAL - 200MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-07-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOPIRAMATE is listed in Drugs@FDA under application 215414 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TOPIRAMATE Form and strength TABLET;ORAL - 200MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-07-17 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.